Crestchem Ltd
₹ 283
-2.65%
22 Nov
- close price
About
Incorporated in 1991, Crestchem Ltd is primarily into manufacturing Nutrition- Chemical Products.
Key Points
- Market Cap ₹ 85.0 Cr.
- Current Price ₹ 283
- High / Low ₹ 350 / 70.0
- Stock P/E 26.8
- Book Value ₹ 21.1
- Dividend Yield 0.18 %
- ROCE 78.2 %
- ROE 56.2 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 42.6%
Cons
- Stock is trading at 13.4 times its book value
- Promoter holding is low: 32.0%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.09 | 0.42 | 0.09 | 0.13 | 0.14 | 0.05 | 0.10 | 6.15 | 7.62 | 7.90 | 16.66 | 21.18 | 26.04 | |
0.26 | 0.36 | 0.23 | 0.18 | 0.34 | 0.29 | 0.26 | 5.59 | 6.95 | 7.15 | 15.84 | 18.40 | 21.93 | |
Operating Profit | -0.17 | 0.06 | -0.14 | -0.05 | -0.20 | -0.24 | -0.16 | 0.56 | 0.67 | 0.75 | 0.82 | 2.78 | 4.11 |
OPM % | -188.89% | 14.29% | -155.56% | -38.46% | -142.86% | -480.00% | -160.00% | 9.11% | 8.79% | 9.49% | 4.92% | 13.13% | 15.78% |
0.22 | 0.03 | 0.89 | 0.19 | 0.08 | 0.03 | 0.02 | 0.03 | 0.05 | 0.08 | 0.15 | 0.26 | 0.35 | |
Interest | 0.04 | 0.03 | 0.02 | 0.02 | 0.04 | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 |
Depreciation | 0.09 | 0.08 | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.05 | 0.04 |
Profit before tax | -0.08 | -0.02 | 0.68 | 0.12 | -0.16 | -0.22 | -0.16 | 0.57 | 0.68 | 0.78 | 0.94 | 2.98 | 4.42 |
Tax % | 0.00% | 0.00% | 10.29% | 25.00% | 0.00% | -13.64% | 0.00% | 22.81% | 14.71% | 26.92% | 26.60% | 27.85% | |
-0.08 | -0.03 | 0.61 | 0.09 | -0.16 | -0.19 | -0.17 | 0.44 | 0.57 | 0.57 | 0.69 | 2.15 | 3.17 | |
EPS in Rs | -0.27 | -0.10 | 2.03 | 0.30 | -0.53 | -0.63 | -0.57 | 1.47 | 1.90 | 1.90 | 2.30 | 7.17 | 10.56 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.98% |
Compounded Sales Growth | |
---|---|
10 Years: | 48% |
5 Years: | 192% |
3 Years: | 41% |
TTM: | 60% |
Compounded Profit Growth | |
---|---|
10 Years: | 54% |
5 Years: | 71% |
3 Years: | 56% |
TTM: | 214% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 87% |
3 Years: | 86% |
1 Year: | 237% |
Return on Equity | |
---|---|
10 Years: | 28% |
5 Years: | 45% |
3 Years: | 43% |
Last Year: | 56% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Reserves | -2.57 | -2.59 | -2.09 | -2.00 | -2.16 | -2.36 | -2.53 | -2.08 | -1.51 | -0.94 | -0.25 | 1.90 | 3.34 |
0.30 | 0.40 | 0.37 | 0.35 | 0.60 | 0.14 | 0.28 | 0.02 | 0.63 | 0.27 | 0.00 | 0.00 | 0.60 | |
0.29 | 0.49 | 0.22 | 0.05 | 0.05 | 0.04 | 0.14 | 1.35 | 0.87 | 0.96 | 2.04 | 2.24 | 1.13 | |
Total Liabilities | 1.02 | 1.30 | 1.50 | 1.40 | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.14 | 8.07 |
0.54 | 0.46 | 0.04 | 0.04 | 0.04 | 0.11 | 0.12 | 0.10 | 0.14 | 0.11 | 0.10 | 0.17 | 0.17 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.48 | 0.84 | 1.46 | 1.36 | 1.45 | 0.71 | 0.77 | 2.19 | 2.85 | 3.18 | 4.69 | 6.97 | 7.90 | |
Total Assets | 1.02 | 1.30 | 1.50 | 1.40 | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.14 | 8.07 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.16 | -0.10 | 0.05 | -0.27 | -0.04 | -0.70 | -0.02 | 0.33 | 0.39 | 0.82 | 2.21 | 0.35 | |
0.19 | 0.02 | 0.06 | 0.34 | 0.64 | 0.12 | 0.01 | -0.35 | -0.39 | -0.83 | -1.34 | -1.07 | |
-0.02 | 0.07 | -0.05 | -0.02 | -0.04 | -0.01 | -0.01 | 0.00 | -0.02 | -0.02 | -0.01 | -0.01 | |
Net Cash Flow | 0.01 | -0.01 | 0.06 | 0.05 | 0.55 | -0.58 | -0.02 | -0.02 | -0.01 | -0.02 | 0.86 | -0.72 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 121.67 | 356.31 | 0.00 | 336.92 | 469.29 | 730.00 | 292.00 | 71.81 | 67.54 | 41.58 | 0.44 | 26.37 |
Inventory Days | 73.00 | 0.00 | 60.83 | 0.00 | 73.00 | 0.00 | 182.50 | 0.75 | 0.00 | 0.00 | 0.00 | 0.00 |
Days Payable | 219.00 | 60.83 | 73.00 | 365.00 | 91.06 | |||||||
Cash Conversion Cycle | -24.33 | 356.31 | 0.00 | 336.92 | 469.29 | 730.00 | 109.50 | -18.50 | 67.54 | 41.58 | 0.44 | 26.37 |
Working Capital Days | -202.78 | 112.98 | -486.67 | 336.92 | 547.50 | 1,460.00 | 730.00 | 4.75 | 43.11 | 9.70 | -36.81 | -1.21 |
ROCE % | -28.00% | 1.30% | -13.40% | 10.65% | -8.60% | -18.92% | -19.61% | 67.46% | 45.75% | 35.96% | 37.40% | 78.17% |
Documents
Announcements
-
Reg. 6&7
14h - Submission of Form-C for promoter share transactions.
-
Regulation 31A Of The SEBI (LODR) Regulations, 2015
1d - Approval of reclassification from promoter to public category.
-
Board Meeting Outcome for Reclassification
1d - Approval of reclassification of shareholding to public category.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 1d
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 2d
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
The company's business comprises manufacturing, processing, marketing, and exporting products derived from Nutraceutical Ingredients from conventional chemical, food, and pharmaceutical fields. The company's products are used in the health food industry like personal care products, and as specialty chemical ingredients.